We provide you with 20 years of free, institutional-grade data for PSTV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PSTV. Explore the full financial landscape of PSTV stock.
| Reported Date | CIK | Ticker | Type |
|---|
Plus Therapeutics(NASDAQ:PSTV) 
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system...
Website: https://www.plustherapeutics.com
Founded: 1996
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about PSTV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.